Dhaka, Oct. 26 -- An artificial intelligence research lab in California has administered a custom AI-designed virus to a human patient for the first time in an attempt to combat antibiotic-resistant superbugs, according to The Independent.

AI startup Radical Numerics announced the experimental treatment, named Omnii-1, which was delivered under a physician-led compassionate-use pathway for a patient with limited remaining medical options.

If verified through peer-reviewed research, the procedure would mark the first time AI-designed bacteriophages -- viruses that specifically target and destroy bacteria -- have been administered to a human, the British news outlet reported.

Traditional phage therapy requires researchers to conduct leng...